Find Maytansinol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 57103-68-1, Zwj9a2aj2u, Nsc-239386, Refchem:156011, 950-267-0, Unii-zwj9a2aj2u
Molecular Formula
C28H37ClN2O8
Molecular Weight
565.1  g/mol
InChI Key
QWPXBEHQFHACTK-RZKXNLMUSA-N
FDA UNII
ZWJ9A2AJ2U

Maytansinol
has antineoplastic activity; structure in first source
1 2D Structure

Maytansinol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-6,21-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaene-8,23-dione
2.1.2 InChI
InChI=1S/C28H37ClN2O8/c1-15-8-7-9-22(37-6)28(35)14-20(38-26(34)30-28)16(2)25-27(3,39-25)21(32)13-23(33)31(4)18-11-17(10-15)12-19(36-5)24(18)29/h7-9,11-12,16,20-22,25,32,35H,10,13-14H2,1-6H3,(H,30,34)/b9-7+,15-8+/t16-,20+,21+,22-,25+,27+,28+/m1/s1
2.1.3 InChI Key
QWPXBEHQFHACTK-RZKXNLMUSA-N
2.2 Other Identifiers
2.2.1 UNII
ZWJ9A2AJ2U
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 57103-68-1

2. Zwj9a2aj2u

3. Nsc-239386

4. Refchem:156011

5. 950-267-0

6. Unii-zwj9a2aj2u

7. Ansamitocin P-0

8. 3-o-de(2-(acetylmethylamino)-1-oxopropyl)maytansine

9. Mfcd28144515

10. (14s,16s,32s,33s,2r,4s,10e,12e,14r)-86-chloro-14,4-dihydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-diene-12,6-dione

11. Maytansine, 3-o-de(2-(acetylmethylamino)-1-oxopropyl)-

12. (1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-6,21-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaene-8,23-dione

13. C28h37cln2o8

14. Ansamitocin P 0

15. Ansamitocin P 0; Antibiotic C 15003p0; Nsc 239386; 3-o-de[2-(acetylmethylamino)-1-oxopropyl]maytansine

16. Maytansinol; Ansamitocin P-0

17. Maytansinol(ansamitocin P-0)?

18. Schembl13558643

19. Qwpxbehqfhactk-rzkxnlmusa-n

20. Ex-a2656

21. Cs-5322

22. Fm44850

23. Hy-19474

24. 3-o-de[2-[methyl(acetyl)amino]-1-oxopropyl]maytansine

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 565.1 g/mol
Molecular Formula C28H37ClN2O8
XLogP31.5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count2
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area130
Heavy Atom Count39
Formal Charge0
Complexity993
Isotope Atom Count0
Defined Atom Stereocenter Count7
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty